Dan Burrows

Dan Burrows

InvestorPlace Feature Writer

Dan Burrows is a veteran of CBS MoneyWatch, DailyFinance, SmartMoney and Dow Jones MarketWatch, and has written for The Wall Street Journal, Consumer Reports and other publications. He favors value investing and writes about asset prices and macroeconomic trends for the long-term investor. He holds no individual securities.

Recent Articles

WEN Stock – Wendy’s Gets No Respect for Street-Beating Results

By Dan Burrows, InvestorPlace Feature Writer

The market remains skeptical of Wendy's success amid brutal competition, as surprisingly strong profit and sales growth was met with selling in WEN stock.

5 Stocks to Buy in May

By Dan Burrows, InvestorPlace Feature Writer

Technicals like price momentum and relative strength indicate that these five market-beating names are strong stocks to buy this month.

Jeffrey Gundlach’s Short Call on Homebuilders Is Dead On

By Dan Burrows, InvestorPlace Feature Writer

Bond King Jeffrey Gundlach is shorting homebuilders and XHB, and for good reason. Weakness in the housing market and poor demographics make a strong bear case.

MRK: Merck Sells Consumer Business to Double Down on Blockbusters

By Dan Burrows, InvestorPlace Feature Writer

Swinging for the fences, MRK sold one of the industry's crown jewels in exchange for an opportunity to find new blockbuster drugs. It's a risky strategy that had better pay off for MRK shareholders.

PFE Stock – Earnings Prove Pfizer Needs AstraZeneca

By Dan Burrows, InvestorPlace Feature Writer

As quarterly results show, PFE stock won't get much long-term support until Pfizer reverse its sales decline -- and that's why it needs AZN.

Load More